Hybio Pharmaceutical (300199) — Free Cash Flow Generation Index
Hybio Pharmaceutical (300199) has a Free Cash Flow Generation Index of 0.19x as of September 2025. Free cash flow of CN¥22.18 Million represents 0% of operating cash flow (CN¥117.78 Million). Read Hybio Pharmaceutical balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hybio Pharmaceutical Free Cash Flow Generation Index (2007–2024)
Historical FCF Generation Index trend for Hybio Pharmaceutical across 17 annual periods. Explore Hybio Pharmaceutical (300199) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Hybio Pharmaceutical (2007–2024)
Year-by-year Free Cash Flow Generation Index for Hybio Pharmaceutical. For the full company profile including market capitalisation, see 300199 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥48.87 Million | CN¥164.71 Million | CN¥115.84 Million | ▲ +102.7% |
| 2022 | -11.01x | CN¥-174.04 Million | CN¥15.81 Million | CN¥189.85 Million | ▼ -3994.5% |
| 2021 | -0.27x | CN¥-42.17 Million | CN¥156.83 Million | CN¥199.00 Million | ▲ +93.4% |
| 2020 | -4.08x | CN¥-195.67 Million | CN¥47.99 Million | CN¥243.66 Million | ▲ +8.4% |
| 2019 | -4.45x | CN¥-465.52 Million | CN¥104.64 Million | CN¥570.15 Million | ▲ +34.4% |
| 2018 | -6.78x | CN¥-318.58 Million | CN¥47.00 Million | CN¥365.58 Million | ▼ -19492.8% |
| 2017 | -0.03x | CN¥-7.39 Million | CN¥213.74 Million | CN¥221.14 Million | ▼ -105.7% |
| 2016 | 0.61x | CN¥180.36 Million | CN¥296.41 Million | CN¥116.05 Million | ▲ +138.4% |
| 2015 | -1.59x | CN¥-220.14 Million | CN¥138.84 Million | CN¥358.98 Million | ▼ -456.4% |
| 2014 | 0.44x | CN¥68.26 Million | CN¥153.43 Million | CN¥85.16 Million | ▲ +145.7% |
| 2013 | -0.97x | CN¥-149.38 Million | CN¥153.48 Million | CN¥302.85 Million | ▲ +36.8% |
| 2012 | -1.54x | CN¥-134.19 Million | CN¥87.19 Million | CN¥221.38 Million | ▼ -1826.5% |
| 2011 | -0.08x | CN¥-5.79 Million | CN¥72.48 Million | CN¥78.27 Million | ▼ -113.7% |
| 2010 | 0.58x | CN¥31.87 Million | CN¥54.69 Million | CN¥22.83 Million | ▼ -11.1% |
| 2009 | 0.66x | CN¥17.10 Million | CN¥26.11 Million | CN¥9.01 Million | ▲ +306.2% |
| 2008 | -0.32x | CN¥-14.53 Million | CN¥45.75 Million | CN¥60.28 Million | ▼ -135.3% |
| 2007 | 0.90x | CN¥44.14 Million | CN¥49.04 Million | CN¥4.90 Million | — |